New drug shows promise for Hard-to-Treat throat cancer
NCT ID NCT05126719
First seen Feb 06, 2026 · Last updated May 19, 2026 · Updated 14 times
Summary
This study tests an experimental drug called MRG003 in adults whose nasopharyngeal cancer has come back or spread and hasn't responded to standard treatments. The main goal is to see if the drug can shrink tumors. About 238 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, 515041, China
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400030, China
-
First Affiliated Hospital of Gannan Medical University
Ganzhou, Jiangxi, 341001, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350014, China
-
Ganzhou Cancer Hospital
Ganzhou, Jiangxi, 341005, China
-
Guangxi Medical University Affiliated Tumor Hospital
Nanning, Guangxi, 530021, China
-
Guigang City People's Hospital
Guigang, Guangxi, 537199, China
-
Hainan General Hospital
Haikou, Hainan, 570311, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410031, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330029, China
-
Maoming People's Hospital
Maoming, Guangdong, 525000, China
-
Peking University Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, 530021, China
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200123, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, 610041, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510000, China
-
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou, 550000, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
Yibin Second People's Hospital
Yibin, Sichuan, 644000, China
-
Yue Bei People's Hospital
Shaoguan, Guangdong, 512026, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
-
Zhongshan City People's Hospital
Zhongshan, Guangdong, 528403, China
Conditions
Explore the condition pages connected to this study.